ARTICLE | Strategy
Outside the box in Quebec
October 20, 2011 7:00 AM UTC
The Quebec Consortium for Drug Discovery has announced C$1.2 million in funding for a quartet of projects that are smaller and riskier than those the consortium has been funding since its inception. For all the projects the consortium funds, it expects the results will yield useful research tools for the consortium's pharma members.
Three pharmas-Pfizer Inc., Merck & Co. Inc. and AstraZeneca plc-founded the Quebec Consortium (CQDM) in 2008. This year, the trio was joined by GlaxoSmithKline plc, Boehringer Ingelheim GmbH and Eli Lilly and Co., and CQDM now includes researchers at 13 academic institutions and hospitals and 11 private companies in Quebec province...